Assuming 2017 is required, the following results were found.

  • Global Primary Progressive Multiple Sclerosis Treatment Market 2019 – F. Hoffmann-La Roche Ltd., Genzyme Corporation, Glialogix, Inc. - Industry Report 24

    Market 2019, with sales, revenue, and price of worldwide Primary Progressive Multiple Sclerosis Treatment, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and...

    https://mschristian.org/index.php/blog/global-primary-progressive-multiple-sclerosis-treatment-market-2019-f-hoffmann-la-roche-ltd-genzyme-corporation-glialogix-inc-industry-report-24
  • Cigarette smoking prevalence continues historic decline

    reported that the U.S. adult smoking prevalence rate for 2018 was 13.7 percent or 34.2 million people, slightly down from 2017. The U.S. adult e-cigarette prevalence rate for 2018 was 3.2 percent, up from 2.8 percent in 2017. Brian King, deputy director...

    https://mschristian.org/index.php/blog/cigarette-smoking-prevalence-continues-historic-decline
  • Blue Cross Blue Shield Association Reports Americans with Multiple Sclerosis are Three Times More Likely to Have Behavioral Health Conditions - BioSpace

    claims from more than 41 million commercially insured members of Blue Cross and Blue Shield (BCBS) companies, from 2014 to 2017. The findings revealed that the average age of someone living with MS is 47 years old. Additional findings from the study...

    https://mschristian.org/index.php/blog/blue-cross-blue-shield-association-reports-americans-with-multiple-sclerosis-are-three-times-more-likely-to-have-behavioral-health-conditions-biospace
  • Biogen Strengthens MS & SMA Portfolio as Competition Lurks - Yahoo Finance

    Tysabri, Tecfidera and Plegridy. It is working on strengthening its position further by bringing new treatments. In November 2017, Biogen in-licensed worldwide commercialization rights to Alkermes’ ALKS Vumerity (BIIB098), which the company claims has a...

    https://mschristian.org/index.php/blog/biogen-strengthens-ms-sma-portfolio-as-competition-lurks-yahoo-finance
  • Electronic Drug Delivery Systems Market Size Reach US$ 12.1 Billion by 2026 - Yahoo Finance

    According to the Centers for Disease Control and Prevention (CDC), 30.3 million people in US, about 1 in 10, had diabetes in 2017. However, Asia Pacific is anticipated to propel the market with the fastest rate during the forecast period due to the...

    https://mschristian.org/index.php/blog/electronic-drug-delivery-systems-market-size-reach-us-12-1-billion-by-2026-yahoo-finance
  • Humira, Rituxan top list of U.S. drugs with biggest price increases: report - Physician's Weekly

    Inc’s arthritis drug Humira and Roche Holding AG’s cancer drug Rituxan topped a list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $5.1 billion increase in U.S. spending, a report released on Tuesday showed. The price...

    https://mschristian.org/index.php/blog/humira-rituxan-top-list-of-u-s-drugs-with-biggest-price-increases-report-physician-s-weekly
  • Syracuse has highest rate of multiple sclerosis in US, study shows - syracuse.com

    An analysis of medical claims by the Blue Cross Blue Shield Association found the multiple diagnosis rate in Syracuse in 2017 was 45 per 10,000 commercially insured people. By comparison, the national multiple diagnosis rate was 24 per 10,000 people,...

    https://mschristian.org/index.php/blog/syracuse-has-highest-rate-of-multiple-sclerosis-in-us-study-shows-syracuse-com
  • Worldwide Genomics Markets, 2020-2027 - Comprehensive Analysis on the $31.1 Billion-Projected Industry - P&T Community

    The company has also begun the commercialization of this technique for newborn's genomic sequencing applications in China in 2017. Further key findings from the report suggest: DUBLIN, Feb. 26, 2020 /PRNewswire/ -- The "Genomics Market Size, Share &...

    https://mschristian.org/index.php/blog/worldwide-genomics-markets-2020-2027-comprehensive-analysis-on-the-31-1-billion-projected-industry-p-t-community
  • REP. CHRIS COLLINS SENTENCED TO 26 MONTHS AND $200,000 - Genesee Sun

    of a drug hoped to treat multiple sclerosis as a board member of an Australian firm, Innate Immunotherapeutics in June 2017. He immediately contacted his son Cameron, who had several million shares in the company to tell him of the failure. Based on the...

    https://mschristian.org/index.php/blog/rep-chris-collins-sentenced-to-26-months-and-200-000-genesee-sun
  • Teenager in Psych Crisis Waits 25 Days in ED for Admission

    room presentations for mental or substance use disorder requiring admission rose by 32% from 2006 to 2014, according to a 2017 report from the Healthcare Cost and Utilization Project. As a result, wait times have increased dramatically. Across 31...

    https://mschristian.org/index.php/blog/teenager-in-psych-crisis-waits-25-days-in-ed-for-admission
  • Friday, January 3, 2020 - California Healthline

    backing up sewage, officials said. The sewage began to spill out of toilets and pipes in the jail at the beginning of 2017, continuing until September 2018. (Garces and Chang, 1/2) The busiest undeveloped intersection in Bakersfield has a new suitor....

    https://mschristian.org/index.php/blog/friday-january-3-2020-california-healthline
  • US FDA wins vapor regulation fight challenging deeming rule

    judgment, according to an article on lexislegalnews.com. U.S. Judge Amy Berman Jackson of the District of Columbia in July 2017 granted summary judgment to the FDA, finding that the FDA’s decision to subject e-cigarettes to premarket authorization was...

    https://mschristian.org/index.php/blog/us-fda-wins-vapor-regulation-fight-challenging-deeming-rule
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis. Mult Scler. 2017;23(5):721-733. doi: 10.1177/1352458517690821. 4. 2018 revised guidelines of the of the Consortium of MS Centers MRI protocol...

    https://mschristian.org/index.php/blog/treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction
  • Cannabis credentials approved for Global Labs

    November 19, 2019 A2LA has renewed accreditation of Global Laboratory Services (GLS) to ISO/IEC 17025:2017 for cannabis testing. Based in Wilson, North Carolina, USA, GLS is the first cannabis testing laboratory accredited in the state. ISO/IEC 17025...

    https://mschristian.org/index.php/blog/cannabis-credentials-approved-for-global-labs
  • Potential genetic markers of multiple sclerosis severity

    old and mostly women (78%). The investigators recruited these patients and performed imaging every few years from 2010 to 2017, yielding an average of 4.6 scans per participant over the course of the study. The scans were used to measure thinning of the...

    https://mschristian.org/index.php/blog/potential-genetic-markers-of-multiple-sclerosis-severity
  • Crain's New York Business Fast 50 List 2019 Honors Schweiger Dermatology Group - P&T Community

    private companies in America as well as the Crain's New York Fast 50, honoring the fastest growing companies in New York for 2017, 2018 and 2019. To learn more, visit schweigerderm.com. Media Contact Schweiger Dermatology Group: Melissa Schweiger...

    https://mschristian.org/index.php/blog/crain-s-new-york-business-fast-50-list-2019-honors-schweiger-dermatology-group-p-t-community
  • How the gut influences neurologic disease

    ScienceDaily. www.sciencedaily.com/releases/2018/05/180516131209.htm (accessed November 2, 2019). RELATED STORIES Nov. 16, 2017 — Humans have roughly as many bacterial cells in their bodies as human cells, and most of those bacteria live in the gut. New...

    https://mschristian.org/index.php/blog/how-the-gut-influences-neurologic-disease
  • Global Multiple Sclerosis Market by Types, Applications, Countries, Companies and Forecasts to 2024 covered in a Latest Research - Market Research Reporting

    Teva and others which are profiled in this report as well in terms of Sales, Price, Revenue, Gross Margin and Market Share (2017-2018). Access Report Details at:...

    https://mschristian.org/index.php/blog/global-multiple-sclerosis-market-by-types-applications-countries-companies-and-forecasts-to-2024-covered-in-a-latest-research-market-research-reporting
  • Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

    Proteomics, Imaging, Clinical) study at the University of California, San Francisco from July 1, 2004, through August 31, 2017. Clinical evaluations and sample collection were performed annually for 5 years, then at different time points for up to 12...

    https://mschristian.org/index.php/blog/association-between-serum-neurofilament-light-chain-levels-and-long-term-disease-course-among-patients-with-multiple-sclerosis-followed-up-for-12-years
  • #ECTRIMS2019 – Data Shows Ublituximab’s Long-term Safety in Relapsing MS, TG Therapeutics Announced

    released early data from a Phase 2 study (NCT0273877) assessing ublitiximab’s safety and efficacy in RMS patients in January 2017. The first part of the study, being led by Edward Fox, director of the Multiple Sclerosis Clinic of Central Texas and a...

    https://mschristian.org/index.php/blog/ectrims2019-data-shows-ublituximab-s-long-term-safety-in-relapsing-ms-tg-therapeutics-announced

Results 1 - 20 of 37
 
 

Follow Us on Twitter

Follow Us On Twitter - Image